Role of dexmedetomidine infusion after coronary artery bypass grafting.
Tamer HamoudaMohamed IsmailTamer Hamed IbrahimHesham EwilaAhmed Farid ElmahroukPublished in: The cardiothoracic surgeon (2020)
Administration of dexmedetomidine in the early postoperative period can be safe. It may reduce the use of opioids, has sedative, analgesic, and sympatholytic effects that could play a useful role during the management of coronary artery bypass patients, and may improve postoperative recovery.
Keyphrases
- coronary artery bypass grafting
- percutaneous coronary intervention
- coronary artery bypass
- end stage renal disease
- patients undergoing
- coronary artery disease
- newly diagnosed
- chronic kidney disease
- cardiac surgery
- chronic pain
- prognostic factors
- peritoneal dialysis
- low dose
- acute coronary syndrome
- patient reported outcomes
- pain management
- acute kidney injury
- anti inflammatory
- spinal cord